WHO ICTRP trial
A 6-month, multicenter, non-interventional Study to evaluate the Effectiveness…
NL-OMON24198 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON24198 |
|---|---|
| Public title | A 6-month, multicenter, non-interventional Study to evaluate the Effectiveness and Quality of life impact of the Insulin glargine/Lixisenatide fixed ratio combination in patients with type 2 diabetes mellitus uncontrolled with basal insulin + metformin ± SU: an observational study |
| Scientific title | A 6-month, multicenter, non-interventional Study to evaluate the Effectiveness and Quality of life impact of the Insulin glargine/Lixisenatide fixed ratio combination in patients with type 2 diabetes mellitus uncontrolled with basal insulin + metformin ± SU: an observational study |
| Primary sponsor | Sanofi |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Conditions | Type 2 Diabetes Mellitus |
| Interventions | No therapeutic interventions. Patients are asked to complete PROs at three different time points (baseline, Month 3, Month 6). |
| Registration date | Apr 2, 2019 |
| Target size | 107 |
| Secondary IDs | NL7648;MEC-U : NWMO19.04.016 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: